These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18615002)

  • 21. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.
    Abdel-Rahman SM; Kauffman RE
    Annu Rev Pharmacol Toxicol; 2004; 44():111-36. PubMed ID: 14744241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-related considerations in clinical pharmacology and drug therapeutics.
    Xie CX; Piecoro LT; Wermeling DP
    Crit Care Nurs Clin North Am; 1997 Dec; 9(4):459-68. PubMed ID: 9444169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation: planning for a source of pharmacokinetic/pharmacodynamic variability in translational studies.
    Schmith VD; Foss JF
    Clin Pharmacol Ther; 2010 Apr; 87(4):488-91. PubMed ID: 20147898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology aspects of sex-related drug products.
    Tran DC; Apparaju S; Yu C; Lee L; Kim H; Kim MJ
    Clin Pharmacol Ther; 2011 Jan; 89(1):26-8. PubMed ID: 21170068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics: has it reached the clinic?
    Schwartz JB
    J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why can't a woman be more like a man?
    Gray J
    Clin Pharmacol Ther; 2007 Jul; 82(1):15-7. PubMed ID: 17571069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacometrics in pregnancy: An unmet need.
    Ke AB; Rostami-Hodjegan A; Zhao P; Unadkat JD
    Annu Rev Pharmacol Toxicol; 2014; 54():53-69. PubMed ID: 24392692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population.
    Hiratsuka M; Hirasawa N; Oshima Y; Kodama S; Miyata T; Dan T; Takatoku H; Kuribayashi H; Nakamura R; Saito Y
    Drug Metab Pharmacokinet; 2018 Jun; 33(3):141-149. PubMed ID: 29703433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of race or ethnicity on pharmacokinetics of drugs.
    Johnson JA
    J Pharm Sci; 1997 Dec; 86(12):1328-33. PubMed ID: 9423140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in drug responses.
    Franconi F; Brunelleschi S; Steardo L; Cuomo V
    Pharmacol Res; 2007 Feb; 55(2):81-95. PubMed ID: 17129734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal clinical pharmacology.
    Allegaert K; van de Velde M; van den Anker J
    Paediatr Anaesth; 2014 Jan; 24(1):30-8. PubMed ID: 23617305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a broad-based ADME panel for use in pharmacogenomic studies.
    Brown AM; Renaud Y; Ross C; Hansen M; Mongrain I; Valois D; Carleton BC; Hayden MR; Dubé MP; Tardif JC; Phillips MS
    Pharmacogenomics; 2014 Jun; 15(9):1185-95. PubMed ID: 25141894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS; Greenberg HE; Reed MD;
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical pharmacologist in drug regulation: the US perspective.
    Temple RJ
    Br J Clin Pharmacol; 1996 Jul; 42(1):73-9. PubMed ID: 8807147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.